v3.26.1
Segments - Schedule of Information by Segment of the Operations for the Year Ended (Details)
 12 Months Ended
Dec. 31, 2025
CNY (¥)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
CNY (¥)
Dec. 31, 2023
CNY (¥)
Schedule of Information by Segment of the Operations for the Year Ended [Line Items]        
Net revenue ¥ 399,914,964 $ 57,187,079 ¥ 342,557,920 ¥ 304,852,971
Less:        
Cost of revenues (347,632,853) (49,710,837) (294,863,867) (266,131,202)
Reconciliation of segment loss:        
Impairment on long-lived assets and long-term assets 2,108,517 301,514 2,238,525 1,107,027
Other income 496,122 70,945 1,238,538 163,622
Other expense 60,325 8,625 37,608 1,336,595
Interest expense 12,885,122 1,842,548 12,964,584 13,849,119
Government grants 152,599 21,821 189,500 321,573
Loss before income tax (130,931,546) (18,722,961) (37,365,434) (36,949,421)
Internet hospital [Member]        
Schedule of Information by Segment of the Operations for the Year Ended [Line Items]        
Net revenue 150,712,158 21,551,552 89,039,600 71,008,971
Less:        
Cost of revenues (101,429,782) (14,504,266) (50,986,600) (35,453,130)
Salaries and welfare (22,158,776) (3,168,663) (19,590,201) (18,773,633)
Commissions to doctors (29,816,464) (4,263,698) (22,685,703) (20,318,748)
Consultancy and professional service fees (21,758,632) (3,111,443) (3,660,677) (4,845,206)
Advertising and promotion costs (17,461,881) (2,497,016) (5,278,798) (1,882,755)
Contracted development and research service fees (9,919,840) (1,418,518)    
Other segment items [1] (14,157,525) (2,024,498) (9,874,409) (6,722,909)
Segment loss (65,990,742) (9,436,550) (23,036,788) (16,987,410)
Pharmaceutical supply chain [Member]        
Schedule of Information by Segment of the Operations for the Year Ended [Line Items]        
Net revenue 249,202,806 35,635,527 253,518,320 233,844,000
Less:        
Cost of revenues (246,203,071) (35,206,571) (243,877,267) (230,678,072)
Salaries and welfare (2,694,321) (385,283) (2,185,872) (1,827,887)
Commissions to doctors
Consultancy and professional service fees (10,891)
Advertising and promotion costs (2,078,012) (297,152) (5,824,158) (1,549,237)
Contracted development and research service fees    
Other segment items [1] (2,039,392) (291,629) (2,146,990) (3,432,378)
Segment loss (3,811,990) (545,108) (515,967) (3,654,465)
Operating Segment [Member]        
Schedule of Information by Segment of the Operations for the Year Ended [Line Items]        
Net revenue 399,914,964 57,187,079 342,557,920 304,852,971
Less:        
Cost of revenues (347,632,853) (49,710,837) (294,863,867) (266,131,202)
Salaries and welfare (24,853,097) (3,553,946) (21,776,073) (20,601,520)
Commissions to doctors (29,816,464) (4,263,698) (22,685,703) (20,318,748)
Consultancy and professional service fees (21,758,632) (3,111,443) (3,660,677) (4,856,097)
Advertising and promotion costs (19,539,893) (2,794,168) (11,102,956) (3,431,992)
Contracted development and research service fees (9,919,840) (1,418,518)    
Other segment items [1] (16,196,917) (2,316,127) (12,021,399) (10,155,287)
Segment loss (69,802,732) (9,981,658) (23,552,755) (20,641,875)
Reconciliation of segment loss:        
Impairment on long-lived assets and long-term assets (2,108,517) (301,514) (2,238,525) (1,607,027)
Other professional service fees (46,723,571) (6,681,382)    
Other income 496,122 70,945 1,238,538 163,622
Other expense (60,325) (8,625) (37,608) (1,336,595)
Interest expense (12,885,122) (1,842,548) (12,964,584) (13,849,119)
Government grants 152,599 21,821 189,500 321,573
Loss before income tax ¥ (130,931,546) $ (18,722,961) ¥ (37,365,434) ¥ (36,949,421)
[1] For each reportable segment, the other segment item category primarily includes shipping expenses, rental costs, entertainment expense, office expense and expected credit losses.